The CHU de Québec-Université Laval (CRCHU) Research Centre has worked extra hard this year to stimulate launches of early-stage clinical research projects in the Quebec City region. The Research Centre is about to double the number of clinical trials conducted in its institutions.
CATALIS Québec launches a promotional campaign to demonstrate Quebec’s expertise in the conduct of early-phase clinical trials and to encourage new partnerships between the biopharmaceutical industry and university research centres.
Clinical trials, cell therapies and partnerships with different specialities: the hematology/oncology research team at the Hôpital de l’Enfant-Jésus (HEJ) in Quebec City is involved in all areas where research can make a difference for its patients.
These reference documents are now available in English.
On August 29th, the management team at the CHUM Research Centre officially opened its Unit for Innovative Therapies (UIT), a competitive infrastructure for early-stage clinical research in Canada.
According to patient and caregiver associations, patients and the public at large should be better informed about clinical trials. Danika Laberge, general manager of CATALIS Québec, brought this subject up for discussion during the annual Innovative Medicines Canada conference on June 18th.
CATALIS’s public and private partners join forces to make Quebec a global leader in the conduct of early-stage clinical trials.
To mark International Clinical Trials Day, on May 20, 2019, we will recognize the commitment of all research professionals who believe in the importance of clinical trials in generating innovative treatments for Quebec’s patients and citizens.
CATALIS and its collaborators have announced the publication of a series of standard operating procedures (SOPs) that meet the highest ethical standards for the conduct of clinical trials in Quebec.
The two organizations are joining forces to maximize the human and economic benefits of clinical trials province-wide.